Simon Adrian Amacher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Simon Adrian Amacher has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Sabina Hunziker
Medical Communication and Psychosomatic Medicine, University Hospital Basel, Basel, Switzerland
6 shared publications - Raoul Sutter
Clinic for Intensive Care, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland
5 shared publications Raoul Sutter
Intensive Care Unit, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland
4 shared publicationsSabina Hunziker
Medical Faculty, University of Basel, Basel, Switzerland
4 shared publications- Christoph Becker
Medical Communication and Psychosomatic Medicine, University Hospital Basel and University of Basel, Switzerland
3 shared publications - Jonas Mueller
Department of Medical Communication and Psychosomatic Medicine, University Hospital Basel, Basel, Switzerland
3 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Postoperative c-reactive protein resolution patterns in patients with and without postoperative atrial fibrillation after cardiac surgery
OBJECTIVES: Postoperative atrial fibrillation is common after cardiac surgery. Effective preventative measures are lacking, partly due to an incomplete understanding of its pathogenesis. Inflammation is a major contributor to postoperative atrial fibrillation development. This study aims to further characterize the association between systemic inflammation and postoperative atrial fibrillation. METHODS: A secondary analysis was conducted on a single-center cohort of patients undergoing cardiac surgery. The original study enrolled 405 cardiac surgery patients. After exclusion of patients with a history of persistent or permanent atrial fibrillation, patients undergoing heart transplantation and patients with incomplete interleukin measurements, 319 patients were included in the present analysis. Postoperative atrial fibrillation was identified through chart review and was defined as at least one AF episode lasting more than 30 seconds, as documented by telemetry or a 12-lead electrocardiogram during the patient’s initial hospitalization. Perioperative levels of interleukins and C-reactive protein were measured. The decline in C-reactive protein levels between postoperative days 3 and 10 was modelled using a linear regression. The association with postoperative atrial fibrillation and other outcomes after cardiac surgery was assessed using logistic and Tobit regression models. RESULTS: Of the 319 patients included in the study, 51% developed postoperative atrial fibrillation, most commonly on postoperative days 2 and 3. Cardiopulmonary bypass and intraoperative ventilation time were significantly associated with an increased risk of postoperative atrial fibrillation. Patients with postoperative atrial fibrillation had longer intensive care unit stays and longer times to extubation. C-reactive protein levels peaked on postoperative day 3 and declined more slowly in postoperative atrial fibrillation patients. A slower C-reactive protein decline was independently associated with postoperative atrial fibrillation (Odds ratio: 1.71, p = 0.046), prolonged postoperative intensive care unit length of stay and time to extubation. Interleukin-10 levels were significantly higher in patients with postoperative atrial fibrillation (Mean ratio: 1.28, p < 0.001). CONCLUSIONS: Postoperative atrial fibrillation is a prevalent complication after cardiac surgery and correlates with a slower postoperative C-reactive protein decline. This study suggests that postoperative atrial fibrillation is associated with delayed resolution of postoperative inflammation.
- 29 June 2026
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (7)
Open AccessPostoperative c-reactive protein resolution patterns in patients with and without postoperative atrial fibrillation after cardiac surgery
OBJECTIVES: Postoperative atrial fibrillation is common after cardiac surgery. Effective preventative measures are lacking, partly due to an incomplete understanding of its pathogenesis. Inflammation is a major contributor to postoperative atrial fibrillation development. This study aims to further characterize the association between systemic inflammation and postoperative atrial fibrillation. METHODS: A secondary analysis was conducted on a single-center cohort of patients undergoing cardiac surgery. The original study enrolled 405 cardiac surgery patients. After exclusion of patients with a history of persistent or permanent atrial fibrillation, patients undergoing heart transplantation and patients with incomplete interleukin measurements, 319 patients were included in the present analysis. Postoperative atrial fibrillation was identified through chart review and was defined as at least one AF episode lasting more than 30 seconds, as documented by telemetry or a 12-lead electrocardiogram during the patient’s initial hospitalization. Perioperative levels of interleukins and C-reactive protein were measured. The decline in C-reactive protein levels between postoperative days 3 and 10 was modelled using a linear regression. The association with postoperative atrial fibrillation and other outcomes after cardiac surgery was assessed using logistic and Tobit regression models. RESULTS: Of the 319 patients included in the study, 51% developed postoperative atrial fibrillation, most commonly on postoperative days 2 and 3. Cardiopulmonary bypass and intraoperative ventilation time were significantly associated with an increased risk of postoperative atrial fibrillation. Patients with postoperative atrial fibrillation had longer intensive care unit stays and longer times to extubation. C-reactive protein levels peaked on postoperative day 3 and declined more slowly in postoperative atrial fibrillation patients. A slower C-reactive protein decline was independently associated with postoperative atrial fibrillation (Odds ratio: 1.71, p = 0.046), prolonged postoperative intensive care unit length of stay and time to extubation. Interleukin-10 levels were significantly higher in patients with postoperative atrial fibrillation (Mean ratio: 1.28, p < 0.001). CONCLUSIONS: Postoperative atrial fibrillation is a prevalent complication after cardiac surgery and correlates with a slower postoperative C-reactive protein decline. This study suggests that postoperative atrial fibrillation is associated with delayed resolution of postoperative inflammation.
- Open Access
- 23 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (4) , oeag095
Sex-specific associations of perioperative Resolvin D1 and D2 dynamics with postoperative atrial fibrillation in cardiac surgery: a secondary analysis of a prospective observational study.
Postoperative atrial fibrillation (POAF) is a prevalent and clinically significant complication that occurs after cardiac surgery. While inflammation has been linked to its onset, the role of active inflammatory resolution-mediated by a group of mediators named specialized pro-resolving mediators (SPMs)-remains unclear. Since SPMs, such as resolvins, actively terminate inflammation and restore tissue homeostasis, impaired resolution could contribute to persistent postoperative inflammation and the development of POAF. This study is a secondary analysis of a single-centre prospective cohort of 319 adult patients who underwent cardiac surgery. The occurrence of POAF was identified. Resolvin D1 (RvD1) and D2 (RvD2) levels were measured during the perioperative period. The association between resolvin levels and POAF was assessed using a mixed-effects Tobit regression model. The interaction between gender, POAF, and resolvin levels was furthermore investigated. Patients who developed POAF exhibited significantly higher predicted perioperative levels of RvD1 [mean ratio (MR-interpreted analogously to an odds ratio): 1.19, P < 0.001] and significantly lower predicted levels of RvD2 (MR: 0.80, P < 0.001) compared to those without POAF. The association between POAF and RvD1 was amplified in women compared to men (P = 0.012). A similar pattern was noted for RvD2, with women tending to show a more pronounced decrease in RvD2 levels associated with POAF. However, this finding did not reach statistical significance (P = 0.054). POAF is associated with elevated RvD1 and reduced RvD2 levels, suggesting a differential response and potentially distinct roles of the two pro-resolving mediators in patients with POAF. Additionally, these associations differ by sex, indicating that inflammatory resolution mechanisms may vary between males and females. German Clinical Trials Registry (DRKS No. 00017057), Date of registration 5 April 2019, www.drks.de.
- 23 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (4) , oeag095
Open AccessSex-specific associations of perioperative Resolvin D1 and D2 dynamics with postoperative atrial fibrillation in cardiac surgery: a secondary analysis of a prospective observational study.
Postoperative atrial fibrillation (POAF) is a prevalent and clinically significant complication that occurs after cardiac surgery. While inflammation has been linked to its onset, the role of active inflammatory resolution-mediated by a group of mediators named specialized pro-resolving mediators (SPMs)-remains unclear. Since SPMs, such as resolvins, actively terminate inflammation and restore tissue homeostasis, impaired resolution could contribute to persistent postoperative inflammation and the development of POAF. This study is a secondary analysis of a single-centre prospective cohort of 319 adult patients who underwent cardiac surgery. The occurrence of POAF was identified. Resolvin D1 (RvD1) and D2 (RvD2) levels were measured during the perioperative period. The association between resolvin levels and POAF was assessed using a mixed-effects Tobit regression model. The interaction between gender, POAF, and resolvin levels was furthermore investigated. Patients who developed POAF exhibited significantly higher predicted perioperative levels of RvD1 [mean ratio (MR-interpreted analogously to an odds ratio): 1.19, P < 0.001] and significantly lower predicted levels of RvD2 (MR: 0.80, P < 0.001) compared to those without POAF. The association between POAF and RvD1 was amplified in women compared to men (P = 0.012). A similar pattern was noted for RvD2, with women tending to show a more pronounced decrease in RvD2 levels associated with POAF. However, this finding did not reach statistical significance (P = 0.054). POAF is associated with elevated RvD1 and reduced RvD2 levels, suggesting a differential response and potentially distinct roles of the two pro-resolving mediators in patients with POAF. Additionally, these associations differ by sex, indicating that inflammatory resolution mechanisms may vary between males and females. German Clinical Trials Registry (DRKS No. 00017057), Date of registration 5 April 2019, www.drks.de.
- Open Access
- 1 September 2025
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (9) , 4625
Prevalence, clinical impact and associated patient-centred outcomes of advance directives in Swiss intensive care units: Results from the retrospective ADVISE Study
STUDY AIMS: Data on the usefulness of advance directives for end-of-life decision-making in intensive care units (ICUs) are scarce. The primary aim of the present study was to investigate the prevalence of advance directives in patients of two Swiss ICUs. To contextualise how advance directives are created, interpreted and translated into clinical practice and which patient profiles influence whether and how patients choose to formulate advance directives, secondary objectives included analysing their content, clinical translation, and associated patient characteristics and outcomes. METHODS: The retrospective cohort study was carried out at two tertiary Swiss ICUs.Data were collected from patients with advance directives treated in ICUs >48 hours from 2020 to 2022.The primary endpoint was the prevalence of advance directives and their content regarding life-prolonging measures, including cardiopulmonary resuscitation (CPR). RESULTS: Of the 5242 patients included, 313 (6.0%) had advance directives. While 290/313 (92.7%) consented to life-prolonging measures other than CPR, CPR was less frequently desired (217/313 [69.3%]). 14.0% (18/129) requested CPR despite declining life-prolonging measures. Fewer women consented to life-prolonging measures and/or CPR than men, whereas prior ICU stays were associated with higher consent rates. Of 104 treatment adaptations, 53 (51.0%) aligned with advance directives, while 33/104 adaptations (31.7%) were based on presumed poor prognosis and 4/104 (3.9%) on surrogate decisions. While patients declining life-prolonging measures experienced faster treatment changes, survival and functional outcomes did not differ based on consent status. CONCLUSIONS:The prevalence of patients with advance directives admitted to Swiss ICUs is low, and substantial obstacles must be overcome in clinical practice. Inconsistent or contradictory contenthighlightsa need for better preemptive communication and documentation of patients’ wishes. Respecting patient autonomy in choosing to forgo life-prolonging measures might not be associated with a lower likelihood of survival or functional outcomes. Trial registration: https://clinicaltrials.gov NCT04348318.
- 1 September 2025
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 155 (9) , 4625
Open AccessPrevalence, clinical impact and associated patient-centred outcomes of advance directives in Swiss intensive care units: Results from the retrospective ADVISE Study
STUDY AIMS: Data on the usefulness of advance directives for end-of-life decision-making in intensive care units (ICUs) are scarce. The primary aim of the present study was to investigate the prevalence of advance directives in patients of two Swiss ICUs. To contextualise how advance directives are created, interpreted and translated into clinical practice and which patient profiles influence whether and how patients choose to formulate advance directives, secondary objectives included analysing their content, clinical translation, and associated patient characteristics and outcomes. METHODS: The retrospective cohort study was carried out at two tertiary Swiss ICUs.Data were collected from patients with advance directives treated in ICUs >48 hours from 2020 to 2022.The primary endpoint was the prevalence of advance directives and their content regarding life-prolonging measures, including cardiopulmonary resuscitation (CPR). RESULTS: Of the 5242 patients included, 313 (6.0%) had advance directives. While 290/313 (92.7%) consented to life-prolonging measures other than CPR, CPR was less frequently desired (217/313 [69.3%]). 14.0% (18/129) requested CPR despite declining life-prolonging measures. Fewer women consented to life-prolonging measures and/or CPR than men, whereas prior ICU stays were associated with higher consent rates. Of 104 treatment adaptations, 53 (51.0%) aligned with advance directives, while 33/104 adaptations (31.7%) were based on presumed poor prognosis and 4/104 (3.9%) on surrogate decisions. While patients declining life-prolonging measures experienced faster treatment changes, survival and functional outcomes did not differ based on consent status. CONCLUSIONS:The prevalence of patients with advance directives admitted to Swiss ICUs is low, and substantial obstacles must be overcome in clinical practice. Inconsistent or contradictory contenthighlightsa need for better preemptive communication and documentation of patients’ wishes. Respecting patient autonomy in choosing to forgo life-prolonging measures might not be associated with a lower likelihood of survival or functional outcomes. Trial registration: https://clinicaltrials.gov NCT04348318.
- 31 May 2025
- Published by Springer Nature
- p. 193-208
Tun oder Nicht-Tun? Herausforderung REA-Nein im Operationssaal
- 31 May 2025
- Published by Springer Nature
- p. 193-208
Tun oder Nicht-Tun? Herausforderung REA-Nein im Operationssaal
- Open Access
- 23 January 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-13
Sex disparities in ICU care and outcomes after cardiac arrest: a Swiss nationwide analysis
Conflicting data exist regarding sex-specific outcomes after cardiac arrest. This study investigates sex disparities in the provision of critical care and outcomes of in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) patients. Analysis of adult cardiac arrest patients admitted to certified Swiss intensive care units (ICUs) (01/2008–12/2022) using the nationwide prospective ICU registry. The primary outcome was ICU mortality, with secondary outcomes including ICU admission probability and advanced treatment provision. Among 41,733 individuals (34.9% women), 21,692 patients (30.6% women) were admitted to ICUs (16,571 OHCA patients/5121 IHCA patients). Women were less likely to be admitted to the ICU than men (incidence rate ratio 0.82 [95% CI 0.80–0.85] and had a higher ICU mortality (41.8% vs 36.2%; p < 0.001). Mortality differences were more pronounced in OHCA patients (unadjusted HR: 1.35 [95% CI 1.28–1.43]; adjusted HR: 1.19 [95% CI 1.12–1.25]). In IHCA patients, mortality differences were less pronounced (unadjusted HR: 1.14 [95% CI 1.04–1.25]) and vanished after adjustment for confounders: adjusted HR: 1.03 [95% CI 0.94–1.13]). Women after cardiac arrest were older, more severely ill, and received fewer interventions before (44.7% vs 54.0%; p < 0.001) and during ICU stay. A subgroup analysis of 11,202 patients revealed that treatment limitations were more frequent in women (46.7% vs 38.7%; p < 0.001). However, these limitations were associated with an increased risk of death in both sexes. This study highlights sex disparities in short-term mortality and ICU resource allocation among cardiac arrest patients, with women potentially facing disadvantages, in particular after OHCA. The limitations of ICU registry data, particularly the lack of detailed cardiac arrest-specific and comorbidity information, restrict definitive conclusions. Future research should prioritize prospective studies with more granular data to better understand and address these disparities.
- 23 January 2025
- Published by Springer Nature in Critical Care
- Vol. 29 (1) , 1-13
Open AccessSex disparities in ICU care and outcomes after cardiac arrest: a Swiss nationwide analysis
Conflicting data exist regarding sex-specific outcomes after cardiac arrest. This study investigates sex disparities in the provision of critical care and outcomes of in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) patients. Analysis of adult cardiac arrest patients admitted to certified Swiss intensive care units (ICUs) (01/2008–12/2022) using the nationwide prospective ICU registry. The primary outcome was ICU mortality, with secondary outcomes including ICU admission probability and advanced treatment provision. Among 41,733 individuals (34.9% women), 21,692 patients (30.6% women) were admitted to ICUs (16,571 OHCA patients/5121 IHCA patients). Women were less likely to be admitted to the ICU than men (incidence rate ratio 0.82 [95% CI 0.80–0.85] and had a higher ICU mortality (41.8% vs 36.2%; p < 0.001). Mortality differences were more pronounced in OHCA patients (unadjusted HR: 1.35 [95% CI 1.28–1.43]; adjusted HR: 1.19 [95% CI 1.12–1.25]). In IHCA patients, mortality differences were less pronounced (unadjusted HR: 1.14 [95% CI 1.04–1.25]) and vanished after adjustment for confounders: adjusted HR: 1.03 [95% CI 0.94–1.13]). Women after cardiac arrest were older, more severely ill, and received fewer interventions before (44.7% vs 54.0%; p < 0.001) and during ICU stay. A subgroup analysis of 11,202 patients revealed that treatment limitations were more frequent in women (46.7% vs 38.7%; p < 0.001). However, these limitations were associated with an increased risk of death in both sexes. This study highlights sex disparities in short-term mortality and ICU resource allocation among cardiac arrest patients, with women potentially facing disadvantages, in particular after OHCA. The limitations of ICU registry data, particularly the lack of detailed cardiac arrest-specific and comorbidity information, restrict definitive conclusions. Future research should prioritize prospective studies with more granular data to better understand and address these disparities.
- Open Access
- 14 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 481
Preoperative Non-Invasive Mapping for Targeted Concomitant Surgical Ablation of Non-Paroxysmal Atrial Fibrillation (PreMap Study)
Background/Objectives: The present study introduces our targeted approach for concomitant surgical ablation (CSA) using non-invasive phase mapping (NIPM) and describes its effectiveness regarding freedom from atrial fibrillation (AF). Methods: This retrospective study included cardiac surgical patients undergoing preoperative NIPM for CSA guidance. The primary outcome was freedom from AF six months after surgery. Key secondary outcomes were freedom from AF at hospital discharge and three months, frequency of biatrial ablation, feasibility and safety, the rate of CSA, complications, and levels of biomarkers. The control group consisted of patients undergoing CSA without NIPM. Results: Forty-four patients (Control: n = 31/NIPM: n = 13) were included. The NIPM group was younger (64 vs. 71 years [p = 0.044]), had a lower EuroSCORE II (2.6 vs. 3.4 [p = 0.041]), and a smaller left atrial size (46 mm vs. 54 mm [p = 0.025]). Surgery duration was longer in the NIPM group (285 vs. 230 min [p = 0.037]) with similar aortic cross-clamp times. Preoperative NIPM resulted in an effective frequency of CSA of 93%. CSA was more extensive in the NIPM group, with biatrial ablation performed in 54% vs. 26% of patients (p = 0.09). Conclusions: Routine preoperative NIPM in patients with non-paroxysmal atrial fibrillation might aid in increasing the number of patients receiving concomitant surgical ablation and developing a personalized CSA approach for every patient.
- 14 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 481
Open AccessPreoperative Non-Invasive Mapping for Targeted Concomitant Surgical Ablation of Non-Paroxysmal Atrial Fibrillation (PreMap Study)
Background/Objectives: The present study introduces our targeted approach for concomitant surgical ablation (CSA) using non-invasive phase mapping (NIPM) and describes its effectiveness regarding freedom from atrial fibrillation (AF). Methods: This retrospective study included cardiac surgical patients undergoing preoperative NIPM for CSA guidance. The primary outcome was freedom from AF six months after surgery. Key secondary outcomes were freedom from AF at hospital discharge and three months, frequency of biatrial ablation, feasibility and safety, the rate of CSA, complications, and levels of biomarkers. The control group consisted of patients undergoing CSA without NIPM. Results: Forty-four patients (Control: n = 31/NIPM: n = 13) were included. The NIPM group was younger (64 vs. 71 years [p = 0.044]), had a lower EuroSCORE II (2.6 vs. 3.4 [p = 0.041]), and a smaller left atrial size (46 mm vs. 54 mm [p = 0.025]). Surgery duration was longer in the NIPM group (285 vs. 230 min [p = 0.037]) with similar aortic cross-clamp times. Preoperative NIPM resulted in an effective frequency of CSA of 93%. CSA was more extensive in the NIPM group, with biatrial ablation performed in 54% vs. 26% of patients (p = 0.09). Conclusions: Routine preoperative NIPM in patients with non-paroxysmal atrial fibrillation might aid in increasing the number of patients receiving concomitant surgical ablation and developing a personalized CSA approach for every patient.
- Open Access
Can the large language model ChatGPT ‐4omni predict outcomes in adult patients with status epilepticus?
Objective: Large language models (LLMs) have recently gained attention for clinical decision‐making and diagnosis. This study evaluates the performance of the recently updated LLM Chat Generative Pre‐Trained Transformer‐4omni (ChatGPT‐4o) in predicting clinical outcomes in patients with status epilepticus and compares its prognostic performance to the Status Epilepticus Severity Score (STESS). Methods: This retrospective single‐center cohort study was performed at the University Hospital Basel (tertiary academic medical center) from January 2005 to December 2022. It included consecutive adult patients (≥18 years of age) with a diagnosis of status epilepticus. The primary outcome was survival at hospital discharge, and the secondary outcome was return to premorbid neurological function at hospital discharge. The performance characteristics of ChatGPT4‐o (sensitivity, specificity, Youden Index) were evaluated and compared to those of the STESS. Results: Of 760 patients, 689 patients (90.7%) survived to discharge, and 317 survivors (41.7%) regained their premorbid neurological function at discharge. ChatGPT‐4o predicted survival in 567 of 760 patients (74.6%), of which 45 died. ChatGPT‐4o predicted death in 193 of 760 patients (25.4%), of which 167 survived, resulting in a sensitivity of 75.8% and a specificity of 36.6% (Youden Index 0.12, 95% confidence interval [CI] 0–.28) for predicting survival. ChatGPT‐4o predicted return to premorbid neurologic function in 249 of 760 patients (32.8%), of which 112 did not return to their premorbid neurological function. ChatGPT‐4o predicted no return to premorbid function in 511 of 760 patients (67.2%), of which 180 returned to their premorbid function, resulting in a sensitivity of 43.2% and a specificity of 74.7% (Youden Index .12, 95% CI .08–.28) for predicting return to premorbid neurological function. There was no difference in the prognostic performance of ChatGPT‐4o and the STESS. A second round of prompting did not increase the predictive performance of ChatGPT‐4o. Significance: ChatGPT‐4o unreliably predicts outcomes in patients with status epilepticus. Clinicians should refrain from using ChatGPT‐4o for prognostication in these patients.
Open AccessCan the large language model ChatGPT ‐4omni predict outcomes in adult patients with status epilepticus?
Objective: Large language models (LLMs) have recently gained attention for clinical decision‐making and diagnosis. This study evaluates the performance of the recently updated LLM Chat Generative Pre‐Trained Transformer‐4omni (ChatGPT‐4o) in predicting clinical outcomes in patients with status epilepticus and compares its prognostic performance to the Status Epilepticus Severity Score (STESS). Methods: This retrospective single‐center cohort study was performed at the University Hospital Basel (tertiary academic medical center) from January 2005 to December 2022. It included consecutive adult patients (≥18 years of age) with a diagnosis of status epilepticus. The primary outcome was survival at hospital discharge, and the secondary outcome was return to premorbid neurological function at hospital discharge. The performance characteristics of ChatGPT4‐o (sensitivity, specificity, Youden Index) were evaluated and compared to those of the STESS. Results: Of 760 patients, 689 patients (90.7%) survived to discharge, and 317 survivors (41.7%) regained their premorbid neurological function at discharge. ChatGPT‐4o predicted survival in 567 of 760 patients (74.6%), of which 45 died. ChatGPT‐4o predicted death in 193 of 760 patients (25.4%), of which 167 survived, resulting in a sensitivity of 75.8% and a specificity of 36.6% (Youden Index 0.12, 95% confidence interval [CI] 0–.28) for predicting survival. ChatGPT‐4o predicted return to premorbid neurologic function in 249 of 760 patients (32.8%), of which 112 did not return to their premorbid neurological function. ChatGPT‐4o predicted no return to premorbid function in 511 of 760 patients (67.2%), of which 180 returned to their premorbid function, resulting in a sensitivity of 43.2% and a specificity of 74.7% (Youden Index .12, 95% CI .08–.28) for predicting return to premorbid neurological function. There was no difference in the prognostic performance of ChatGPT‐4o and the STESS. A second round of prompting did not increase the predictive performance of ChatGPT‐4o. Significance: ChatGPT‐4o unreliably predicts outcomes in patients with status epilepticus. Clinicians should refrain from using ChatGPT‐4o for prognostication in these patients.
- Open Access
- 27 December 2023
- Published by Elsevier in Journal of Intensive Medicine
- Vol. 4 (3) , 318-325
Adverse events related to physical restraint use in intensive care units: A review of the literature
- 27 December 2023
- Published by Elsevier in Journal of Intensive Medicine
- Vol. 4 (3) , 318-325
Open AccessAdverse events related to physical restraint use in intensive care units: A review of the literature
- Open Access
- 4 April 2023
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 31 (1) , 1-11
External validation of the PROLOGUE score to predict neurological outcome in adult patients after cardiac arrest: a prospective cohort study
Background: The PROLOGUE score (PROgnostication using LOGistic regression model for Unselected adult cardiac arrest patients in the Early stages) is a novel prognostic model for the prediction of neurological outcome after cardiac arrest, which showed exceptional performance in the internal validation. The aim of this study is to validate the PROLOGUE score in an independent cohort of unselected adult cardiac arrest patients and to compare it to the thoroughly validated Out-of-Hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP) scores. Methods: This study included consecutive adult cardiac arrest patients admitted to the intensive care unit (ICU) of a Swiss tertiary teaching hospital between October 2012 and July 2022. The primary endpoint was poor neurological outcome at hospital discharge, defined as a Cerebral Performance Category (CPC) score of 3 to 5 including death. Results: Of 687 patients included in the analysis, 321 (46.7%) survived to hospital discharge with good neurological outcome, 68 (9.9%) survived with poor neurological outcome and 298 (43.4%) died. The PROLOGUE score showed an area under the receiver operating characteristic curve (AUROC) of 0.83 (95% CI 0.80 to 0.86) and good calibration for the prediction of the primary outcome. The OHCA and CAHP score showed similar performance (AUROC 0.83 and 0.84 respectively), the differences between the three scores were not significant (p = 0.495). In a subgroup analysis, the PROLOGUE score performed equally in out-of-hospital and in-hospital cardiac arrest patients whereas the OHCA and CAHP score performed significantly better in OHCA patients. Conclusion: The PROLOGUE score showed good prognostic accuracy for the early prediction of neurological outcome in adult cardiac arrest survivors in our cohort and might support early goals-of-care discussions in the ICU. Trial registration Not applicable.
- 4 April 2023
- Published by Springer Nature in Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
- Vol. 31 (1) , 1-11
Open AccessExternal validation of the PROLOGUE score to predict neurological outcome in adult patients after cardiac arrest: a prospective cohort study
Background: The PROLOGUE score (PROgnostication using LOGistic regression model for Unselected adult cardiac arrest patients in the Early stages) is a novel prognostic model for the prediction of neurological outcome after cardiac arrest, which showed exceptional performance in the internal validation. The aim of this study is to validate the PROLOGUE score in an independent cohort of unselected adult cardiac arrest patients and to compare it to the thoroughly validated Out-of-Hospital Cardiac Arrest (OHCA) and Cardiac Arrest Hospital Prognosis (CAHP) scores. Methods: This study included consecutive adult cardiac arrest patients admitted to the intensive care unit (ICU) of a Swiss tertiary teaching hospital between October 2012 and July 2022. The primary endpoint was poor neurological outcome at hospital discharge, defined as a Cerebral Performance Category (CPC) score of 3 to 5 including death. Results: Of 687 patients included in the analysis, 321 (46.7%) survived to hospital discharge with good neurological outcome, 68 (9.9%) survived with poor neurological outcome and 298 (43.4%) died. The PROLOGUE score showed an area under the receiver operating characteristic curve (AUROC) of 0.83 (95% CI 0.80 to 0.86) and good calibration for the prediction of the primary outcome. The OHCA and CAHP score showed similar performance (AUROC 0.83 and 0.84 respectively), the differences between the three scores were not significant (p = 0.495). In a subgroup analysis, the PROLOGUE score performed equally in out-of-hospital and in-hospital cardiac arrest patients whereas the OHCA and CAHP score performed significantly better in OHCA patients. Conclusion: The PROLOGUE score showed good prognostic accuracy for the early prediction of neurological outcome in adult cardiac arrest survivors in our cohort and might support early goals-of-care discussions in the ICU. Trial registration Not applicable.
- Open Access
- 14 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0276011
Post-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study
Introduction: Intensive care unit patients are at risk for post-intensive care syndrome (PICS), which includes psychological, physical and/or cognitive sequelae after their hospital stay. Our aim was to investigate PICS in adult patients with out-of-hospital cardiac arrest (OHCA). Methods: In this prospective observational cohort study, we assessed risks for PICS at 3 and 12-month follow-up within the following domains: a) physical impairment (EuroQol [EQ-5D-3L]), b) cognitive functioning (Cerebral Performance Category [CPC] score >1, modified Rankin Scale [mRS] >2) and c) psychological burden (Hospital Anxiety and Depression Scale [HADS], Impact of Event Scale-Revised [IES-R]). Results: At 3 months, 69/139 patients (50%) met the definition of PICS including 37% in the physical domain, 25% in the cognitive domain and 13% in the psychological domain. Intubation (OR 2.3, 95%CI 1.1 to 5,0 p = 0.03), sedatives (OR 3.4, 95%CI 1 to 11, p = 0.045), mRS at discharge (OR 4.3, 95%CI 1.70 to 11.01, p = 0.002), CPC at discharge (OR 3.3, 95%CI 1.4 to 7.6, p = 0.005) and post-discharge work loss (OR 13.4, 95%CI 1.7 to 107.5, p = 0.014) were significantly associated with PICS. At 12 months, 52/110 (47%) patients had PICS, which was associated with prolonged duration of rehabilitation, higher APACHE scores, and higher mRS and CPC scores at hospital discharge. Conclusions: Nearly half of long-term OHCA survivors show PICS after 3 and 12 months. These high numbers call for more emphasis on appropriate screening and treatment in this patient population. Future studies should evaluate whether early identification of these patients enables preventive strategies and treatment options.
- 14 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0276011
Open AccessPost-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study
Introduction: Intensive care unit patients are at risk for post-intensive care syndrome (PICS), which includes psychological, physical and/or cognitive sequelae after their hospital stay. Our aim was to investigate PICS in adult patients with out-of-hospital cardiac arrest (OHCA). Methods: In this prospective observational cohort study, we assessed risks for PICS at 3 and 12-month follow-up within the following domains: a) physical impairment (EuroQol [EQ-5D-3L]), b) cognitive functioning (Cerebral Performance Category [CPC] score >1, modified Rankin Scale [mRS] >2) and c) psychological burden (Hospital Anxiety and Depression Scale [HADS], Impact of Event Scale-Revised [IES-R]). Results: At 3 months, 69/139 patients (50%) met the definition of PICS including 37% in the physical domain, 25% in the cognitive domain and 13% in the psychological domain. Intubation (OR 2.3, 95%CI 1.1 to 5,0 p = 0.03), sedatives (OR 3.4, 95%CI 1 to 11, p = 0.045), mRS at discharge (OR 4.3, 95%CI 1.70 to 11.01, p = 0.002), CPC at discharge (OR 3.3, 95%CI 1.4 to 7.6, p = 0.005) and post-discharge work loss (OR 13.4, 95%CI 1.7 to 107.5, p = 0.014) were significantly associated with PICS. At 12 months, 52/110 (47%) patients had PICS, which was associated with prolonged duration of rehabilitation, higher APACHE scores, and higher mRS and CPC scores at hospital discharge. Conclusions: Nearly half of long-term OHCA survivors show PICS after 3 and 12 months. These high numbers call for more emphasis on appropriate screening and treatment in this patient population. Future studies should evaluate whether early identification of these patients enables preventive strategies and treatment options.